HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contact Bioassays with Phenoxybenzyl and Tetrafluorobenzyl Pyrethroids against Target-Site and Metabolic Resistant Mosquitoes.

AbstractBACKGROUND:
Mosquito strains that exhibit increased tolerance to the chemical class of compounds with a sodium channel modulator mode of action (pyrethroids and pyrethrins) are typically described as "pyrethroid resistant". Resistance to pyrethroids is an increasingly important challenge in the control of mosquito-borne diseases, such as malaria or dengue, because one of the main interventions (the distribution of large numbers of long-lasting insecticide-treated bed nets) currently relies entirely on long-lasting pyrethroids. Increasing tolerance of target insects against this class of insecticides lowers their impact in vector control. The current study suggests that the level of metabolic resistance depends on the structure of the molecule and that structurally different compounds may still be effective because detoxifying enzymes are unable to bind to these uncommon structures.
METHODS:
Treated surface contact bioassays were performed on susceptible Aedes aegypti, East African knockdown resistance (kdr) Anopheles gambiae (strain RSP-H) and metabolically resistant Anopheles funestus (strain FUMOZ-R) with different pyrethroids, such as cypermethrin, ß-cyfluthrin, deltamethrin, permethrin and transfluthrin (alone and in combination with the synergist piperonyl butoxide). The nonfluorinated form of transfluthrin was also assessed as a single agent and in combination with piperonyl butoxide.
RESULTS:
Although the dosages for pyrethroids containing a phenoxybenzyl moiety have exhibited differences in terms of effectiveness among the three tested mosquito species, the structurally different transfluthrin with a polyfluorobenzyl moiety remained active in mosquitoes with upregulated P450 levels. In trials with transfluthrin mixed with piperonyl butoxide, the added synergist exhibited no efficacy-enhancing effect.
CONCLUSION:
The results of this study suggest that transfluthrin has the potential to control P450-mediated metabolically resistant mosquitoes because the structural formula of transfluthrin differs from that of the tested pyrethroids, which are used in vector control. The P450-detoxifying enzymes of the Anopheles funestus FUMOZ-R mosquitoes seem to bind preferably at the phenoxybenzyl moiety and appear to be unable to degrade transfluthrin with its tetrafluorobenzyl moiety. Inhibition of the class of monooxygenases by piperonyl butoxide revealed no increase of efficacy of the pure transfluthrin compound, which also indicates that the P450 enzymes potentially do not impact the efficacy of transfluthrin.
AuthorsSebastian Horstmann, Rainer Sonneck
JournalPloS one (PLoS One) Vol. 11 Issue 3 Pg. e0149738 ( 2016) ISSN: 1932-6203 [Electronic] United States
PMID26930058 (Publication Type: Journal Article)
Chemical References
  • Cyclopropanes
  • Fluorobenzenes
  • Insecticides
  • Nitriles
  • Pyrethrins
  • cypermethrin
  • decamethrin
  • Permethrin
  • Cytochrome P-450 Enzyme System
  • transfluthrin
  • cyfluthrin
Topics
  • Aedes (growth & development, metabolism)
  • Animals
  • Anopheles (growth & development, metabolism)
  • Binding Sites
  • Biological Assay (methods)
  • Cyclopropanes (chemistry, metabolism, pharmacology)
  • Cytochrome P-450 Enzyme System (metabolism)
  • Dose-Response Relationship, Drug
  • Fluorobenzenes (chemistry, metabolism, pharmacology)
  • Insecticide Resistance (drug effects)
  • Insecticides (chemistry, metabolism, pharmacology)
  • Molecular Structure
  • Mosquito Control (methods)
  • Nitriles (chemistry, metabolism, pharmacology)
  • Permethrin (chemistry, metabolism, pharmacology)
  • Pyrethrins (chemistry, metabolism, pharmacology)
  • Reproducibility of Results

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: